Sebivo and cardiac arrest Patient Reports February 12, 2012

Sebivo Side Effects Report #6047154-1
Sebivo side effect was reported by a Physician from CHINA on Jan 15, 2009. Male patient, 18 years of age, was diagnosed with hepatitis b  and was treated with Sebivo. After drug was administered, patient experienced the following side effects: alpha haemolytic streptococcal infection, blood creatine phosphokinase increased, blood pressure decreased, blood uric acid increased, cardiac arrest , dysphagia, dyspnoea, endotracheal intubation, hepatic function abnormal. Sebivo dosage: 600 MG, QD. During the same period patient was treated with LAMIVUDINE. Patient was hospitalized. Patient died on 12/29/2008.

Sebivo Side Effects Report #6051836-5
Sebivo side effect was reported by a Physician from CHINA on Jan 21, 2009. Male patient, 18 years of age, was diagnosed with hepatitis b  and was treated with Sebivo. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, blood lactate dehydrogenase increased, blood pressure decreased, cardiac arrest , dysphagia, dyspnoea, endotracheal intubation, hepatic function abnormal, hepatitis b . Sebivo dosage: 600 MG, QD. During the same period patient was treated with LAMIVUDINE. Patient was hospitalized. Patient died on 12/29/2008.

Sebivo Side Effects Report #6068739-2
Sebivo side effect was reported by a Physician from CHINA on Jan 21, 2009. Male patient, 18 years of age, was diagnosed with hepatitis b  and was treated with Sebivo. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, blood lactate dehydrogenase increased, blood pressure decreased, cardiac arrest , dysphagia, dyspnoea, endotracheal intubation, hepatic function abnormal, hepatitis b . Sebivo dosage: 600 MG, QD. During the same period patient was treated with LAMIVUDINE. Patient was hospitalized. Patient died on 12/29/2008.

Sebivo Side Effects Report #6086085-8
Sebivo side effect was reported by a Physician from CHINA on Feb 18, 2009. Male patient, 18 years of age, was diagnosed with hepatitis b  and was treated with Sebivo. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, blood creatine phosphokinase increased, blood lactate dehydrogenase increased, blood pressure decreased, cardiac arrest , dysphagia, dyspnoea, endotracheal intubation, hepatic function abnormal. Sebivo dosage: 600 MG, QD. During the same period patient was treated with LAMIVUDINE. Patient was hospitalized. Patient died on 12/29/2008.